115 related articles for article (PubMed ID: 2967730)
1. [Blood levels of dehydroepiandrosterone sulfate (DHEA-S) and the risk of breast cancer].
Gomes P; Cassanas G; Halberg F; Hermida R; Robel P; Baulieu EE; Lakatua D; Haus E
C R Acad Sci III; 1988; 306(7):261-4. PubMed ID: 2967730
[TBL] [Abstract][Full Text] [Related]
2. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
Helzlsouer KJ; Gordon GB; Alberg AJ; Bush TL; Comstock GW
Cancer Res; 1992 Jan; 52(1):1-4. PubMed ID: 1530765
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone sulfate and breast cancer risk.
Barrett-Connor E; Friedlander NJ; Khaw KT
Cancer Res; 1990 Oct; 50(20):6571-4. PubMed ID: 2145063
[TBL] [Abstract][Full Text] [Related]
4. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
5. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
[TBL] [Abstract][Full Text] [Related]
6. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.
Gordon GB; Bush TL; Helzlsouer KJ; Miller SR; Comstock GW
Cancer Res; 1990 Jul; 50(13):3859-62. PubMed ID: 2141293
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
8. Chronobiologic pattern discrimination of plasma hormones, notably DHEA-S and TSH, classifies an expansive personality.
Hermida RC; Halberg F; del Pozo F
Chronobiologia; 1985; 12(2):105-36. PubMed ID: 3161711
[TBL] [Abstract][Full Text] [Related]
9. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
10. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
Comstock GW; Gordon GB; Hsing AW
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):219-21. PubMed ID: 8318873
[TBL] [Abstract][Full Text] [Related]
11. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer.
Gordon GB; Helzlsouer KJ; Alberg AJ; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):33-5. PubMed ID: 8420609
[TBL] [Abstract][Full Text] [Related]
13. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
[TBL] [Abstract][Full Text] [Related]
14. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy.
Morris KT; Toth-Fejel S; Schmidt J; Fletcher WS; Pommier RF
Surgery; 2001 Dec; 130(6):947-53. PubMed ID: 11742322
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer.
Gordon GB; Helzlsouer KJ; Comstock GW
Cancer Res; 1991 Mar; 51(5):1366-9. PubMed ID: 1825478
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of exercise training on dehydroepiandrosterone-sulfate.
Milani RV; Lavie CJ; Barbee RW; Littman AB
Am J Med Sci; 1995 Dec; 310(6):242-6. PubMed ID: 7503104
[TBL] [Abstract][Full Text] [Related]
17. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
[TBL] [Abstract][Full Text] [Related]
18. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
19. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
[TBL] [Abstract][Full Text] [Related]
20. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
Lewy H; Haus E; Ashkenazi IE
Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
